News Archives | Center for U.S. Policy

DEA Proposes Rules for Permanent Telemedicine Flexibilities

DEA Proposes Rules for Permanent Telemedicine Flexibilities

News March 1, 2023

Millennium Health Report on Polysubstance Use in 2022

Millennium Health Report on Polysubstance Use in 2022

News February 28, 2023

DEA Concludes Delta-8 and Delta-9 THC-O are Controlled Substances

DEA Concludes Delta-8 and Delta-9 THC-O are Controlled Substances

News February 28, 2023

Federal Court Overturns CSA Conviction Following Ruan

Federal Court Overturns CSA Conviction Following Ruan

News February 23, 2023

Some Lawmakers Fear Buprenorphine Diversion After X-Waiver Eliminated

Some Lawmakers Fear Buprenorphine Diversion After X-Waiver Eliminated

News February 18, 2023

Biden Administration Announces 2023 Plans to Address Drug Poisoning Crisis

Biden Administration Announces 2023 Plans to Address Drug Poisoning Crisis

News February 9, 2023

Cost of Opioid Use Disorder

Cost of Opioid Use Disorder

News February 5, 2023

DEA To Propose Telehealth Regulations

DEA To Propose Telehealth Regulations

News February 2, 2023

CMS Approves California’s Section 1115 Waiver to Expand Medicaid to Incarcerated Individuals

CMS Approves California’s Section 1115 Waiver to Expand Medicaid to Incarcerated Individuals

News February 1, 2023

FDA Announces Need for New Regulatory Pathway for CBD

FDA Announces Need for New Regulatory Pathway for CBD

News January 30, 2023

DEA Announces Removal of Buprenorphine Waiver Requirements

DEA Announces Removal of Buprenorphine Waiver Requirements

News January 30, 2023

NIH Supports Broad Portfolio of Cannabis Research

NIH Supports Broad Portfolio of Cannabis Research

News January 25, 2023